By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
there appears to be a discrepancy in the recommendations. in the body of the report it indicates il-6 and hbsag neg, hb core + suggests low risk on hnvr; the algorithm above suggests moderate risk.
same with jak inhibitors.